Loading...
Market
What will be Biogen's non-GAAP diluted EPS for full year 2024?
2
Resolution / Starting Odds
Below $16.10 • 25%
$16.10 to $16.60 • 25%
$16.61 to $17.10 • 25%
Above $17.10 • 25%
Biogen's full-year 2024 earnings report
Story
Biogen Raises Guidance as Leqembi Sales Boost Q3 Earnings, Stock Rises
Oct 31, 2024, 10:38 AM
Biogen Inc. reported stronger-than-expected third-quarter earnings for 2024 and raised its full-year earnings guidance, as cost-cutting measures helped offset declining sales of its multiple sclerosis medications. The company increased its full-year non-GAAP diluted EPS guidance to between $16.10 and $16.60, up from the previous range of $15.75 to $16.25. Biogen's revenue for the quarter was $2.5 billion, with GAAP diluted EPS of $2.66 and non-GAAP diluted EPS of $4.08, surpassing analysts' estimates. Sales of its Alzheimer's drug Leqembi contributed to the positive results, generating global in-market sales of $67 million, including $39 million in the United States. The company's stock rose after the announcement, reflecting investor optimism in Biogen's performance and outlook.
View original story
Similar markets
Below $3.60 • 25%
$3.60 to $3.75 • 25%
$3.76 to $3.90 • 25%
Above $3.90 • 25%
Higher than competitors • 25%
On par with competitors • 25%
Lower than competitors • 25%
Significantly lower than competitors • 25%
Below $1.00 • 25%
$1.00 to $1.25 • 25%
$1.26 to $1.50 • 25%
Above $1.50 • 25%
$2.80 - $2.85 • 25%
$2.86 - $2.90 • 25%
$2.91 - $2.95 • 25%
$2.96 - $3.00 • 25%
Below $4.61 • 25%
$4.61 - $4.65 • 25%
$4.66 - $4.70 • 25%
$4.71 or above • 25%
Below $6.10 • 25%
$6.10 to $6.20 • 25%
$6.21 to $6.35 • 25%
Above $6.35 • 25%
Negative EPS • 25%
$0.00 to $0.50 • 25%
$0.51 to $1.00 • 25%
More than $1.00 • 25%
Below $27.1 billion • 25%
$27.1 billion to $27.3 billion • 25%
$27.31 billion to $27.5 billion • 25%
Above $27.5 billion • 25%
Below $45 billion • 25%
$45 billion to $45.5 billion • 25%
$45.5 billion to $46 billion • 25%
Above $46 billion • 25%
Below $27.50 • 25%
$27.50 to $27.75 • 25%
$27.76 to $28.00 • 25%
Above $28.00 • 25%